2026/158: AC4 - CLINICAL RESEARCH ASSOCIATE (CRA)
Call for applications for an AC4 - Clinical Research Associate (CRA) to join the Clinical Oncology Research Group. Application deadline: 24 November 2026, at 3:00 p.m.
About the Unit
The group conducts clinical trials to evaluate new therapeutic strategies, the efficacy of targeted treatments and the detection of residual disease. It also carries out studies focusing on prognostic and predictive molecular biomarkers, the molecular mechanisms of drug action and resistance, and cancer pharmacogenetics.
Furthermore, the group has expanded its activities to include clinical trials involving radiopharmaceuticals and theranostics, establishing nuclear medicine as a key strategic partner. Its aim is to identify minimal residual disease, improve treatment personalisation, advance translational research and contribute to expanding the range of therapeutic options available for cancer treatment.
Essential Requirements
- Minimum educational qualification: Higher education degree (Bachelor's degree or equivalent university qualification) in Health Sciences.
- Specific training in clinical trials (Master's degree in Clinical Trial Monitoring).
- Training in Good Clinical Practice (GCP) and quality standards.
- At least 2 years of documented professional experience.
- Oral and written proficiency in both official languages of Catalonia. Alternatively, the selected candidate must demonstrate adequate proficiency or undertake to acquire an appropriate level of proficiency in both official languages of Catalonia within a maximum period of one year.
- Intermediate level of English.
- Intermediate proficiency in office software applications (Excel, Word, PowerPoint, etc.).
The Following Will Be Valued
- Previous experience in oncology clinical trials, particularly in rare cancers.
- Previous experience working with cooperative research groups in Spain.
Duties
The responsibilities of this position are linked to the monitoring of the international Lutecin clinical trial. The main duties will include:
- Communication liaison: acting as the main point of contact between the study sponsor (pharmaceutical company or Contract Research Organisation, CRO) and the clinical research team at the participating healthcare centre.
- Site monitoring: conducting monitoring visits to participating hospitals or clinical sites to oversee study progress.
- Data verification: comparing original patient medical records with the study's electronic Case Report Forms (eCRFs) to ensure data accuracy.
- Regulatory and ethical compliance: ensuring strict adherence to the clinical trial protocol, Good Clinical Practice (GCP) guidelines and applicable legislation.
- Patient safety: verifying that informed consent forms have been properly signed and overseeing the appropriate reporting of adverse events.
- Investigational medicinal product management: overseeing the inventory, storage, dispensing and return of investigational medicinal products.
Types of visits to be conducted:
- Site Selection Visits (SSVs): assessing whether a healthcare centre has the appropriate facilities, resources and qualified personnel to participate in the clinical trial.
- Site Initiation Visits (SIVs): ensuring that the site is fully prepared and providing training to the clinical research team before participant recruitment begins.
- Monitoring Visits (MVs): conducting regular visits throughout the trial to review study data, documentation and participant safety.
- Close-Out Visits (COVs): completing study activities at the participating site and ensuring that all required documentation is appropriately archived.
We Offer
-
Permanent employment contract linked to the project: "Adjuvant chemotherapy in patients with CINSARC high-risk localized Uterine Leiomyosarcoma".This contract will be funded by the Fundación Mari Paz Jiménez Casado (FMPJC), grant reference BECA TRIENAL FMPJC 2025, and the Grupo Español de Investigación en Sarcomas (GEIS), grant reference BECA BUESA 2025-1.
- Annual working hours: 347.2 hours (8 hours per week).
- Salary in accordance with the applicable collective bargaining agreement.
- Research Group: Clinical Oncology.
Documentació i termini de presentació
Interested candidates should preferably submit the required documents in PDF format by email to the Management of the Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at seleccio@recercasantpau.cat, indicating reference number 2026/158.
Required documents:
- Application letter.
- Updated curriculum vitae (CV).
- AUTHORISATION FOR THE PROCESSING OF PERSONAL DATA
The deadline for submitting applications is 24 November 2026, at 3:00 p.m.